Stocksigma LogoStocksigma Logo

Biopol Chemicals Reports Zero Deviation in SME IPO Proceeds Utilization

Biopol Chemicals Limited reported no deviation or variation in utilizing its SME IPO proceeds for the period ended 30th Sep'26

Biopol Chemicals Reports Zero Deviation in SME IPO Proceeds Utilization

Biopol Chemicals Ltd · Others (Uncategorized) · 05 Nov 2026, 11:27 pm

Biopol Chemicals Reports Zero Deviation in SME IPO Proceeds Utilization Biopol Chemicals Limited reported no deviation or variation in utilizing its SME IPO proceeds for the period ended 30th Sep'26. Out of the total ₹3,125.95 lakhs raised on 11th Feb'26, the company deployed ₹3,108.71 lakhs, leaving ₹17.24 lakhs unutilized. Capital deployment includes ₹1,226.47 lakhs for industrial land acquisition, ₹1,092.76 lakhs toward debt repayment/prepayment (against ₹1,110.00 lakhs allocated), ₹404.23 lakhs for general corporate purposes, and ₹385.25 lakhs for issue-related expenses. Both the audit committee and statutory auditor confirmed compliance with prospectus objects.

Original exchange filing (PDF)

More announcements from Biopol Chemicals Ltd

All Biopol Chemicals Ltd announcements